174 related articles for article (PubMed ID: 30107597)
41. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
42. Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas with MRI: Single-Shell versus Multishell Diffusion Models.
Figini M; Riva M; Graham M; Castelli GM; Fernandes B; Grimaldi M; Baselli G; Pessina F; Bello L; Zhang H; Bizzi A
Radiology; 2018 Dec; 289(3):788-796. PubMed ID: 30277427
[TBL] [Abstract][Full Text] [Related]
43. Clinical implications of TERT promoter mutation on IDH mutation and MGMT promoter methylation in diffuse gliomas.
Kim HS; Kwon MJ; Song JH; Kim ES; Kim HY; Min KW
Pathol Res Pract; 2018 Jun; 214(6):881-888. PubMed ID: 29650441
[TBL] [Abstract][Full Text] [Related]
44. Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas.
Macaulay RJ
Cancer Control; 2015 Apr; 22(2):200-5. PubMed ID: 26068765
[TBL] [Abstract][Full Text] [Related]
45. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
[TBL] [Abstract][Full Text] [Related]
46. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features.
Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D
Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026
[TBL] [Abstract][Full Text] [Related]
47. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
48. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
49. Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.
Zhang T; Wang Y; Fan X; Ma J; Li S; Jiang T; Wang L
J Neurol Sci; 2014 Nov; 346(1-2):94-8. PubMed ID: 25130928
[TBL] [Abstract][Full Text] [Related]
50. Impact of gross total resection in patients with WHO grade III glioma harboring the IDH 1/2 mutation without the 1p/19q co-deletion.
Kawaguchi T; Sonoda Y; Shibahara I; Saito R; Kanamori M; Kumabe T; Tominaga T
J Neurooncol; 2016 Sep; 129(3):505-514. PubMed ID: 27401154
[TBL] [Abstract][Full Text] [Related]
51. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
[TBL] [Abstract][Full Text] [Related]
52. Use of preoperative FLAIR MRI and ependymal proximity of tumor enhancement as surrogate markers of brain tumor origin.
Smith TR; Hulou MM; Abecassis J; Das S; Chandler JP
J Clin Neurosci; 2015 Sep; 22(9):1397-402. PubMed ID: 26055954
[TBL] [Abstract][Full Text] [Related]
53. GC/MS-based metabolomic analysis of cerebrospinal fluid (CSF) from glioma patients.
Nakamizo S; Sasayama T; Shinohara M; Irino Y; Nishiumi S; Nishihara M; Tanaka H; Tanaka K; Mizukawa K; Itoh T; Taniguchi M; Hosoda K; Yoshida M; Kohmura E
J Neurooncol; 2013 May; 113(1):65-74. PubMed ID: 23456655
[TBL] [Abstract][Full Text] [Related]
54. Brain atlas for assessing the impact of tumor location on perioperative quality of life in patients with high-grade glioma: A prospective population-based cohort study.
Sagberg LM; Iversen DH; Fyllingen EH; Jakola AS; Reinertsen I; Solheim O
Neuroimage Clin; 2019; 21():101658. PubMed ID: 30655192
[TBL] [Abstract][Full Text] [Related]
55. MRI features can predict EGFR expression in lower grade gliomas: A voxel-based radiomic analysis.
Li Y; Liu X; Xu K; Qian Z; Wang K; Fan X; Li S; Wang Y; Jiang T
Eur Radiol; 2018 Jan; 28(1):356-362. PubMed ID: 28755054
[TBL] [Abstract][Full Text] [Related]
56. Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement.
Chang K; Beers AL; Bai HX; Brown JM; Ly KI; Li X; Senders JT; Kavouridis VK; Boaro A; Su C; Bi WL; Rapalino O; Liao W; Shen Q; Zhou H; Xiao B; Wang Y; Zhang PJ; Pinho MC; Wen PY; Batchelor TT; Boxerman JL; Arnaout O; Rosen BR; Gerstner ER; Yang L; Huang RY; Kalpathy-Cramer J
Neuro Oncol; 2019 Nov; 21(11):1412-1422. PubMed ID: 31190077
[TBL] [Abstract][Full Text] [Related]
57. Statistical evaluation of manual segmentation of a diffuse low-grade glioma MRI dataset.
Ben Abdallah M; Blonski M; Wantz-Mezieres S; Gaudeau Y; Taillandier L; Moureaux JM
Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():4403-4406. PubMed ID: 28269254
[TBL] [Abstract][Full Text] [Related]
58. Mapping seizure foci and tumor genetic factors in glioma associated seizure patients.
Yunhe M; Yuan Y; Xiang W; Yanhui L; Qing M
J Neurosurg Sci; 2020 Oct; 64(5):456-463. PubMed ID: 28497669
[TBL] [Abstract][Full Text] [Related]
59. New insights into glioma frequency maps: From genetic and transcriptomic correlate to survival prediction.
Bao H; Ren P; Yi L; Lv Z; Ding W; Li C; Li S; Li Z; Yang X; Liang X; Liang P
Int J Cancer; 2023 Mar; 152(5):998-1012. PubMed ID: 36305649
[TBL] [Abstract][Full Text] [Related]
60. Computational Identification of Tumor Anatomic Location Associated with Survival in 2 Large Cohorts of Human Primary Glioblastomas.
Liu TT; Achrol AS; Mitchell LA; Du WA; Loya JJ; Rodriguez SA; Feroze A; Westbroek EM; Yeom KW; Stuart JM; Chang SD; Harsh GR; Rubin DL
AJNR Am J Neuroradiol; 2016 Apr; 37(4):621-8. PubMed ID: 26744442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
